APG SGA SA Logo

APG SGA SA

Switzerland's leading OOH media firm offering digital and analogue outdoor advertising solutions.

APGN.SW | SW

Overview

Corporate Details

ISIN(s):
CH0019107025
LEI:
Country:
Switzerland
Address:
Carrefour de Rive 1, 1207 Genève
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

APG SGA SA is Switzerland's leading Out-of-Home (OOH) media company, specializing in digital and analogue outdoor advertising solutions. The company manages and markets an extensive network of advertising spaces in public and private areas, including streets, public transport, and points of sale. Its offerings range from traditional posters to digital, mobile, and interactive advertising formats. APG SGA provides services for local, regional, and national campaigns, enabling clients to reach broad audiences through its diverse media assets.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2019-06-26 09:00
M&A Activity
Acquisition of US forecourt operation
English 15.2 KB
2019-05-09 13:33
Major Shareholding Notification
Holding(s) in Company
English 45.7 KB
2019-05-08 16:57
Major Shareholding Notification
Holding(s) in Company
English 14.4 KB
2019-05-02 20:10
Report Publication Announcement
Posting of Annual Report and Notice of AGM
English 13.4 KB

Automate Your Workflow. Get a real-time feed of all APG SGA SA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for APG SGA SA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for APG SGA SA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-09-17 N/A Executive member Sell None 40,000.00 CHF
2024-08-26 N/A Executive member Sell None 51,239.38 CHF
2024-08-19 N/A Executive member Sell None 39,569.04 CHF
2024-08-19 N/A Executive member Sell None 2,587.00 CHF
2024-08-16 N/A Executive member Sell None 5,373.00 CHF
2024-08-13 N/A Executive member Sell None 14,726.00 CHF
2023-11-10 N/A Executive member Buy None 19,504.60 CHF
2023-08-08 N/A Executive member Sell None 27,225.00 CHF
2022-04-29 N/A Executive member Buy None 46,500.00 CHF
2022-04-07 N/A Executive member Buy None 24,948.00 CHF

Peer Companies

Nuvectis Pharma, Inc. Logo
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea
476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan
4564

Talk to a Data Expert

Have a question? We'll get back to you promptly.